Back
Expedia Group, Inc. 10K Form
Buy
83
EXPE
Expedia Group, Inc.
Last Price:
$258.25
Seasonality Move:
1.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-11-15 | 10K | EXPE/Expedia Group, Inc. Annual |
| 2025-10-15 | 10K | EXPE/Expedia Group, Inc. Annual |
| 2025-09-15 | 10K | EXPE/Expedia Group, Inc. Annual |
Receive EXPE News And Ratings
See the #1 stock for the next 7 days that we like better than EXPE
EXPE Financial Statistics
Sales & Book Value
| Annual Sales: | $13.7B |
|---|---|
| Cash Flow: | $-686M |
| Price / Cash Flow: | 11.56 |
| Annual Sales: | $10.87 |
| Price / Book: | 24.05 |
Profitability
| EPS (TTM): | 10.45280 |
|---|---|
| Net Income (TTM): | $1.4B |
| Gross Margin: | $11.4B |
| Return on Equity: | 56.21% |
| Return on Assets: | 5.61% |
Expedia Group, Inc. Earnings Forecast
Key Expedia Group, Inc. Financial Ratios
-
The Gross Profit Margin over the past 24 years for EXPE is 83.34%.
-
The Selling, General & Administrative Expenses for EXPE have been equal to 61.59% of Gross Profit Margin.
-
The Research & Development expenses have been 9.60% of Revenue.
-
The Interest Expense is 20.10% of Operating Income.
-
The Net Earning history of EXPE is 8.94% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 16 years.
Expedia Group, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Hotels, Restaurants & Leisure |
| Sector: | Consumer Discretionary |
| Current Symbol: | EXPE |
| CUSIP: | 30212P |
| Website: | expediagroup.com |
Debt
| Debt-to-Equity Ratio: | 4.85 |
|---|---|
| Current Ratio: | 0.74 |
| Quick Ratio: | 0.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.33 |
|---|---|
| Forward P/E Ratio: | 14.74 |
EXPE Technical Analysis vs Fundamental Analysis
Buy
83
Expedia Group, Inc. (EXPE)
is a Buy
Is Expedia Group, Inc. a Buy or a Sell?
-
Expedia Group, Inc. stock is rated a BuyThe current Expedia Group, Inc. [EXPE] share price is $258.38. The Score for EXPE is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.